Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA7 | P43166 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7230309 | 0.84 | ALDH1A1 (0.35) | CA1CA2CA7CA9CA12 | |
| SCHEMBL160639 | 0.82 | PGR (0.36) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9340384 | 0.81 | NPC1 (0.32) | CA1CA2CA7CA9CA12 | |
| SCHEMBL6638430 | 0.80 | TAAR1 (0.35) | ALDH1A1CYP1A2CYP3A4MAPTMEN1 | |
| SCHEMBL29020367 | 0.74 | ALDH1A1 (0.53) | ALDH1A1CYP3A4GAAMAPTMEN1 | |
| SCHEMBL28206151 | 0.74 | ALDH1A1 (0.37) | ALDH1A1CYP1A2GAAMAPTMEN1 | |
| SCHEMBL301056 | 0.73 | ALDH1A1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL15066961 | 0.73 | ALDH1A1 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1777557 | 0.71 | TSHR (0.33) | CA2ALDH1A1CYP1A2ACHECYP2A6 | |
| SCHEMBL160135 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117136188-A | Process for preparing enantiomerically enriched forms of 2- [2- (2-chlorothiazol-5-yl) -2-hydroxyethyl ] sulfanyl-6-hydroxy-3-methyl-5-phenylpyrimidin-4-one by hydrogenation of 2-oxo derivatives in the presence of chiral transition metal catalysts | 巴斯夫欧洲公司 | 2023-11-28 | — | — | CN | claimed |
| CN-113557227-A | Method for producing prostaglandin | 协和医药化工股份有限公司 | 2021-10-26 | — | — | CN | claimed |
| WO-2020195437-A1 | METHOD FOR PRODUCING PKROSTAGLANDIN | 協和ファーマケミカル株式会社 | 2020-10-01 | — | — | WO | claimed |
| US-7294729-B2 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2007-11-13 | — | — | US | claimed |
| US-20060058557-A1 | Bis-chelating ligand and use thereof in carbonylation processes | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC | 2006-03-16 | — | — | US | claimed |
| EP-1554293-A1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2005-07-20 | — | — | EP | claimed |
| WO-2004035595-A1 | BIS-CHELATING LIGAND AND USE THEREOF IN CARBONYLATION PROCESSES | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2004-04-29 | — | — | WO | claimed |
| US-20030003358-A1 | Thermal runaway inhibitors | ENERGY, UNITED STATES, DEPARTMENT OF | 2003-01-02 | — | — | US | claimed |
| US-5981530-A | FOR TREATMENT OF ALLERGIC DISEASES | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | claimed |
| US-5061584-A | Photosensitive layer contains butadiene, hydrazone and mono-phenol compounds; does not crack when oil drops or fingprints adhere to it | SHINDENGEN ELECTRIC MANUFACTURING CO., LTD (JP) | 1991-10-29 | — | — | US | claimed |
| CN-118103532-A | Method for recovering rhodium from a hydroformylation process | 陶氏技术投资有限责任公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117693496-A | Oligomerization process in a reactor having a variable diameter zone comprising a step of recycling pre-cooled solvent | IFP 新能源公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-112533889-B | Process for oligomerization in cascade with stirred gas-liquid reactor staged injection of ethylene | IFP 新能源公司 | 2024-03-05 | — | — | CN | disclosed |
| CN-117136188-A | Process for preparing enantiomerically enriched forms of 2- [2- (2-chlorothiazol-5-yl) -2-hydroxyethyl ] sulfanyl-6-hydroxy-3-methyl-5-phenylpyrimidin-4-one by hydrogenation of 2-oxo derivatives in the presence of chiral transition metal catalysts | 巴斯夫欧洲公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117120401-A | Oligomerization process comprising a step of recycling pre-cooled solvent | IFP 新能源公司 | 2023-11-24 | — | — | CN | disclosed |
| US-4309335-A | THERMAL AGING RESISTANCE; ORTHO-SUBSTITUTED PHENYL ACID PHOSPHITE | ADEKA ARGUS CHEMICAL CO., LTD. | 1982-01-05 | — | — | US | disclosed |
| EP-0038876-A1 | 2,6-Di-tertiary butyl phenyl pentaerythritol spiro bis-phosphites enhancing the stability to heat and light of synthetic resins, stabilizer compositions comprising phenolic antioxidants and such phosphites, and synthetic resin compositions containing the same | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-11-04 | — | — | EP | disclosed |
| EP-0033395-A2 | 2,6-Di-tertiary butyl phenyl phosphites and synthetic resin compositions containing these phosphites | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-08-12 | — | — | EP | disclosed |
| US-4282141-A | DISCOLORATION INHIBITION FOR VINYL CHLORIDE POLYMERS | ARGUS CHEMICAL CORPORATION (US) | 1981-08-04 | — | — | US | disclosed |
| EP-0032681-A2 | Hindered bis-phenol phenyl phosphites and synthetic resin compositions having enhanced stability to heat and light | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1981-07-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058557-A1 | Bis-chelating ligand and use thereof in carbonylation processes | CBR1, CBR3, AR | CA1 924/4885CA2 217/4885CA7 1524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.